Akanda Corp美股招股说明书(2026-01-14版)

Issuance of up to 3,752,212 Common Shares Akanda Corp. This prospectus supplement (the “Prospectus Supplement”) is being filed to update and supplement our prospectus contained in ourRegistration Statement on Form F-1, dated September 29, 2025 (the “Prospectus”), relating to the resale, from time to time of up to an aggregate of3,752,212 common shares (post-reverse stock split), no par value, of Akanda Corp. (“Common Shares”), by the selling stockholders named elsewherein the Prospectus (“Selling Stockholders”). The Selling Stockholders may receive the Common Shares included in the Prospectus upon the conversionof principal and interest under outstanding convertible promissory notes of the Company in the aggregate principal amount of $12,000,000 held by Specifically, this Prospectus Supplement is being filed to update and supplement the information included in the Prospectus with certaininformation contained in our Report on Form 6-K, which was submitted to the U.S. Securities and Exchange Commission (the “SEC”) on January 8,2026 (the “Form 6-K”). Accordingly, we have attached the Form 6-K to this Prospectus Supplement. Any statement contained in the Prospectus shall Capitalized terms used but not defined herein have the meanings ascribed to them in the Prospectus. This Prospectus Supplement is not complete without, and may not be utilized except in connection with, the Prospectus, including anysupplements and amendments thereto. We may further amend or supplement the Prospectus and this Prospectus Supplement from time to time by filing amendments or supplementsas required. You should read the entire Prospectus, this Prospectus Supplement and any amendments or supplements carefully before you make your Our Common Shares are listed on The Nasdaq Capital Market under the symbol “AKAN”. The closing price of our Common Share asreported by the Nasdaq Capital Market on January 12, 2026, was $2.63. None of our Class A Special Shares or Class B Special Shares are or will be Investing in our Common Shares involves significant risks. You should read the section entitled “Risk Factors” beginning on page 15of the Prospectus for a discussion of certain risk factors that you should consider before investing in our Common Shares. Neither the Securities and Exchange Commission nor any state securities commission or other regulatory body has approved ordisapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminaloffense. The date of this Prospectus Supplement is January 13, 2026 INFORMATION CONTAINED IN THIS FORM 6-K REPORT Attached hereto as Exhibit 99.1 and Exhibit 99.2 and incorporated by reference herein are Akanda Corp.’s press release, dated January 8, 2026, andAkanda Corp.’s Articles and Certificate of Amendment, respectively. The press release furnished in this report as Exhibit 99.1 shall not be deemed to be “filed” for the purposes of Section 18 of the Securities ExchangeAct of 1934 or otherwise subject to the liabilities of that section. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by theundersigned, thereunto duly authorized. Date:January 8, 2026 Name:Katie FieldTitle:Interim Chief Executive Officer and Director Akanda Corp. Announces Reverse Stock Split TORONTO, ON January 8, 2026 — Akanda Corp. (NASDAQ: AKAN) (the “Company” or “Akanda”), today announced that it expects to implement a1-for-5 reverse stock split of the Company’s common shares effective January 12, 2026. The reverse stock split was previously approved by theCompany’s shareholders on November 28, 2025 and Board of Directors on December 23, 2025 and will begin trading on an adjusted basis giving effectto the reverse stock split at the opening of market on January 12, 2026 under the existing ticker symbol “AKAN”. The new CUSIP number of the In accordance with the proposal approved by the Company’s shareholders on November 28, 2025, the Company may effect one or more futureconsolidations of the Company’s issued and outstanding common shares and on the basis of a consolidation ratio to be selected by the Board, in its solediscretion, within a range between two pre-consolidation common shares for one post-consolidation common share and 100 pre-consolidation commonshares for one post-consolidation common share, on such dates as the Board may determine. Since then, the Board has determined to approve a reverse Outstanding Company options, warrants and other applicable convertible securities will be proportionately adjusted in accordance with their respectiveterms. No fractional shares will be issued in connection with the reverse stock split. In the event that a shareholder would otherwise be entitled to Vstock Transfer is acting as exchange agent for the reverse stock split and will send instructions to any shareholders of record who hold stockcertifica